MedTrace Logo

Effect of Dexmedetomidine for Postoperative Intravenous Patient Controlled Analgesia

NCT03014713 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2017-01-09

No results posted yet for this study

Summary

The purpose of this study is to explore the effectiveness of dexmedetomidine as an adjunctive analgesic, combined with dezocine and flubiprofen, used in intravenous Patient-Controlled Analgesia (PCA) after open colorectal surgery.

Conditions

  • Patient-Controlled Analgesia

Interventions

DRUG

Dezocine

Dezocine 0.01mg/kg/h intravenous administration during the first two days after surgery.

DRUG

Flubiprofen

Flubiprofen 0.5mg/kg/h intravenous administration during the first two days after surgery.

DRUG

Dexmedetomidine

Dexmedetomidine 0.1μg/kg/h intravenous administration during the first two days after surgery.

Sponsors & Collaborators

  • Weifeng Tu

    lead OTHER

Principal Investigators

  • Weifeng Tu, PhD · Guangzhou General Hospital of Guangzhou Military Command

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-09-30
Primary Completion
2017-12-31
Completion
2017-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03014713 on ClinicalTrials.gov